Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Cost of Revenue: 2017-2019

Historic Cost of Revenue for Neurocrine Biosciences (NBIX) over the last 3 years, with Dec 2019 value amounting to $7.4 million.

  • Neurocrine Biosciences' Cost of Revenue rose 55.56% to $4.2 million in Q3 2021 from the same period last year, while for Sep 2021 it was $12.9 million, marking a year-over-year increase of 32.61%. This contributed to the annual value of $7.4 million for FY2019, which is 51.93% up from last year.
  • Per Neurocrine Biosciences' latest filing, its Cost of Revenue stood at $7.4 million for FY2019, which was up 51.93% from $4.9 million recorded in FY2018.
  • Over the past 5 years, Neurocrine Biosciences' Cost of Revenue peaked at $7.4 million during FY2019, and registered a low of $1.3 million during FY2017.
  • In the last 3 years, Neurocrine Biosciences' Cost of Revenue had a median value of $4.9 million in 2018 and averaged $4.5 million.
  • Data for Neurocrine Biosciences' Cost of Revenue shows a peak YoY skyrocketed of 289.87% (in 2018) over the last 5 years.
  • Neurocrine Biosciences' Cost of Revenue (Yearly) stood at $1.3 million in 2017, then surged by 289.87% to $4.9 million in 2018, then spiked by 51.93% to $7.4 million in 2019.